Annual Net Income
$17.78 M
+$49.62 M+155.84%
30 June 2024
Summary:
MEI Pharma annual net profit is currently $17.78 million, with the most recent change of +$49.62 million (+155.84%) on 30 June 2024. During the last 3 years, it has risen by +$59.09 million (+143.03%). MEIP annual net income is now at all-time high.MEIP Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$8.01 M
+$10.40 M+56.50%
30 September 2024
Summary:
MEI Pharma quarterly net profit is currently -$8.01 million, with the most recent change of +$10.40 million (+56.50%) on 30 September 2024. Over the past year, it has dropped by -$64.38 million (-114.20%). MEIP quarterly net income is now -114.20% below its all-time high of $56.37 million, reached on 30 September 2023.MEIP Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$46.60 M
-$64.38 M-362.14%
30 September 2024
Summary:
MEI Pharma TTM net profit is currently -$46.60 million, with the most recent change of -$64.38 million (-362.14%) on 30 September 2024. Over the past year, it has dropped by -$87.76 million (-213.22%). MEIP TTM net income is now -213.22% below its all-time high of $41.16 million, reached on 30 September 2023.MEIP TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Net Income Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +155.8% | -114.2% | -213.2% |
3 y3 years | +143.0% | +54.3% | +21.7% |
5 y5 years | +205.7% | -167.4% | -784.1% |
MEIP Net Income High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +132.7% | -114.2% | +56.5% | -213.2% | +26.8% |
5 y | 5 years | at high | +132.7% | -114.2% | +68.8% | -213.2% | +26.8% |
alltime | all time | at high | +132.7% | -114.2% | +68.8% | -213.2% | +26.8% |
MEI Pharma Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$8.01 M(-56.5%) | -$46.60 M(-362.1%) |
June 2024 | $17.78 M(-155.8%) | -$18.41 M(+101.7%) | $17.78 M(-32.0%) |
Mar 2024 | - | -$9.13 M(-17.5%) | $26.16 M(+31.8%) |
Dec 2023 | - | -$11.06 M(-119.6%) | $19.84 M(-51.8%) |
Sept 2023 | - | $56.37 M(-662.1%) | $41.16 M(-229.3%) |
June 2023 | -$31.84 M(-41.5%) | -$10.03 M(-35.0%) | -$31.84 M(-15.9%) |
Mar 2023 | - | -$15.44 M(-250.6%) | -$37.87 M(+21.5%) |
Dec 2022 | - | $10.25 M(-161.7%) | -$31.16 M(-41.8%) |
Sept 2022 | - | -$16.62 M(+3.5%) | -$53.57 M(-1.6%) |
June 2022 | -$54.45 M(+31.8%) | -$16.06 M(+84.1%) | -$54.45 M(+16.4%) |
Mar 2022 | - | -$8.72 M(-28.2%) | -$46.77 M(-26.5%) |
Dec 2021 | - | -$12.16 M(-30.6%) | -$63.67 M(+6.9%) |
Sept 2021 | - | -$17.51 M(+109.0%) | -$59.54 M(+44.1%) |
June 2021 | -$41.31 M(-12.4%) | -$8.38 M(-67.3%) | -$41.31 M(-21.4%) |
Mar 2021 | - | -$25.62 M(+219.2%) | -$52.57 M(+68.1%) |
Dec 2020 | - | -$8.03 M(-1227.2%) | -$31.28 M(-28.0%) |
Sept 2020 | - | $712.00 K(-103.6%) | -$43.47 M(-7.9%) |
June 2020 | -$47.17 M(+180.5%) | -$19.63 M(+353.5%) | -$47.17 M(+92.6%) |
Mar 2020 | - | -$4.33 M(-78.6%) | -$24.49 M(-34.7%) |
Dec 2019 | - | -$20.22 M(+575.3%) | -$37.51 M(+611.7%) |
Sept 2019 | - | -$2.99 M(-198.1%) | -$5.27 M(-68.7%) |
June 2019 | -$16.82 M(-58.0%) | $3.05 M(-117.6%) | -$16.82 M(-57.0%) |
Mar 2019 | - | -$17.36 M(-244.3%) | -$39.13 M(+41.2%) |
Dec 2018 | - | $12.03 M(-182.7%) | -$27.72 M(-39.5%) |
Sept 2018 | - | -$14.54 M(-24.5%) | -$45.82 M(+14.4%) |
June 2018 | -$40.07 M(-1600.7%) | -$19.25 M(+223.7%) | -$40.07 M(+59.3%) |
Mar 2018 | - | -$5.95 M(-2.2%) | -$25.16 M(+27.0%) |
Dec 2017 | - | -$6.08 M(-30.8%) | -$19.81 M(+972.1%) |
Sept 2017 | - | -$8.79 M(+102.3%) | -$1.85 M(-169.2%) |
June 2017 | $2.67 M(-112.8%) | -$4.34 M(+621.4%) | $2.67 M(+114.8%) |
Mar 2017 | - | -$602.00 K(-105.1%) | $1.24 M(-135.3%) |
Dec 2016 | - | $11.88 M(-378.3%) | -$3.53 M(-82.8%) |
Sept 2016 | - | -$4.27 M(-26.0%) | -$20.51 M(-1.7%) |
June 2016 | -$20.86 M(-36.2%) | -$5.77 M(+7.4%) | -$20.86 M(+0.5%) |
Mar 2016 | - | -$5.37 M(+5.3%) | -$20.75 M(-14.6%) |
Dec 2015 | - | -$5.10 M(+10.4%) | -$24.31 M(-14.2%) |
Sept 2015 | - | -$4.62 M(-18.4%) | -$28.32 M(-13.4%) |
June 2015 | -$32.69 M(+20.4%) | -$5.66 M(-36.6%) | -$32.69 M(-8.1%) |
Mar 2015 | - | -$8.93 M(-2.0%) | -$35.57 M(+4.5%) |
Dec 2014 | - | -$9.11 M(+1.3%) | -$34.03 M(+8.9%) |
Sept 2014 | - | -$8.99 M(+5.3%) | -$31.25 M(+15.1%) |
June 2014 | -$27.15 M | -$8.54 M(+15.6%) | -$27.15 M(+24.4%) |
Mar 2014 | - | -$7.39 M(+16.8%) | -$21.82 M(+27.0%) |
Dec 2013 | - | -$6.32 M(+29.2%) | -$17.19 M(+26.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2013 | - | -$4.90 M(+52.3%) | -$13.62 M(+21.7%) |
June 2013 | -$11.19 M(+48.7%) | -$3.21 M(+16.8%) | -$11.19 M(+11.1%) |
Mar 2013 | - | -$2.75 M(-0.0%) | -$10.07 M(+5.0%) |
Dec 2012 | - | -$2.75 M(+11.8%) | -$9.59 M(+14.5%) |
Sept 2012 | - | -$2.46 M(+17.3%) | -$8.38 M(+11.3%) |
June 2012 | -$7.52 M(+10.9%) | -$2.10 M(-7.4%) | -$7.52 M(+6.5%) |
Mar 2012 | - | -$2.27 M(+47.2%) | -$7.06 M(+15.7%) |
Dec 2011 | - | -$1.54 M(-4.4%) | -$6.11 M(-7.9%) |
Sept 2011 | - | -$1.61 M(-1.8%) | -$6.63 M(-2.2%) |
June 2011 | -$6.78 M(-14.1%) | -$1.64 M(+25.2%) | -$6.78 M(-2.9%) |
Mar 2011 | - | -$1.31 M(-36.6%) | -$6.98 M(-11.4%) |
Dec 2010 | - | -$2.07 M(+17.6%) | -$7.88 M(+8.8%) |
Sept 2010 | - | -$1.76 M(-4.5%) | -$7.25 M(-8.2%) |
June 2010 | -$7.90 M(-29.4%) | -$1.84 M(-16.8%) | -$7.90 M(-31.2%) |
Mar 2010 | - | -$2.21 M(+54.4%) | -$11.48 M(+2.8%) |
Dec 2009 | - | -$1.43 M(-40.5%) | -$11.17 M(-1.5%) |
Sept 2009 | - | -$2.41 M(-55.6%) | -$11.34 M(+1.4%) |
June 2009 | -$11.18 M(-9.9%) | -$5.42 M(+184.9%) | -$11.18 M(+22.1%) |
Mar 2009 | - | -$1.90 M(+19.1%) | -$9.16 M(-13.5%) |
Dec 2008 | - | -$1.60 M(-29.0%) | -$10.58 M(-6.3%) |
Sept 2008 | - | -$2.25 M(-33.8%) | -$11.30 M(-9.0%) |
June 2008 | -$12.41 M(-10.2%) | -$3.40 M(+2.1%) | -$12.41 M(+12.3%) |
Mar 2008 | - | -$3.33 M(+44.2%) | -$11.05 M(+17.0%) |
Dec 2007 | - | -$2.31 M(-31.3%) | -$9.44 M(+1.5%) |
Sept 2007 | - | -$3.37 M(+64.8%) | -$9.31 M(-32.7%) |
June 2007 | -$13.82 M(+87.1%) | -$2.04 M(+18.5%) | -$13.82 M(+12.1%) |
Mar 2007 | - | -$1.72 M(-20.8%) | -$12.33 M(-11.0%) |
Dec 2006 | - | -$2.17 M(-72.4%) | -$13.86 M(+2.9%) |
Sept 2006 | - | -$7.88 M(+1325.0%) | -$13.46 M(+82.3%) |
June 2006 | -$7.39 M(+15.0%) | -$553.00 K(-83.0%) | -$7.39 M(-17.1%) |
Mar 2006 | - | -$3.25 M(+82.9%) | -$8.91 M(+20.4%) |
Dec 2005 | - | -$1.78 M(-1.4%) | -$7.40 M(+5.8%) |
Sept 2005 | - | -$1.80 M(-13.2%) | -$6.99 M(+8.9%) |
June 2005 | -$6.42 M(-24.8%) | -$2.08 M(+19.3%) | -$6.42 M(+15.8%) |
Mar 2005 | - | -$1.74 M(+26.5%) | -$5.55 M(+3.7%) |
Dec 2004 | - | -$1.38 M(+11.8%) | -$5.35 M(-38.2%) |
Sept 2004 | - | -$1.23 M(+2.4%) | -$8.65 M(+1.4%) |
June 2004 | -$8.54 M(+181.5%) | -$1.20 M(-22.1%) | -$8.54 M(+0.2%) |
Mar 2004 | - | -$1.54 M(-67.1%) | -$8.52 M(+12.5%) |
Dec 2003 | - | -$4.68 M(+320.3%) | -$7.58 M(+161.6%) |
Sept 2003 | - | -$1.11 M(-6.1%) | -$2.90 M(+62.4%) |
June 2003 | -$3.03 M(+2365.9%) | -$1.19 M(+98.8%) | -$1.78 M(+198.8%) |
Mar 2003 | - | -$597.00 K | -$597.00 K |
June 2002 | -$123.00 K | - | - |
FAQ
- What is MEI Pharma annual net profit?
- What is the all time high annual net income for MEI Pharma?
- What is MEI Pharma annual net income year-on-year change?
- What is MEI Pharma quarterly net profit?
- What is the all time high quarterly net income for MEI Pharma?
- What is MEI Pharma quarterly net income year-on-year change?
- What is MEI Pharma TTM net profit?
- What is the all time high TTM net income for MEI Pharma?
- What is MEI Pharma TTM net income year-on-year change?
What is MEI Pharma annual net profit?
The current annual net income of MEIP is $17.78 M
What is the all time high annual net income for MEI Pharma?
MEI Pharma all-time high annual net profit is $17.78 M
What is MEI Pharma annual net income year-on-year change?
Over the past year, MEIP annual net profit has changed by +$49.62 M (+155.84%)
What is MEI Pharma quarterly net profit?
The current quarterly net income of MEIP is -$8.01 M
What is the all time high quarterly net income for MEI Pharma?
MEI Pharma all-time high quarterly net profit is $56.37 M
What is MEI Pharma quarterly net income year-on-year change?
Over the past year, MEIP quarterly net profit has changed by -$64.38 M (-114.20%)
What is MEI Pharma TTM net profit?
The current TTM net income of MEIP is -$46.60 M
What is the all time high TTM net income for MEI Pharma?
MEI Pharma all-time high TTM net profit is $41.16 M
What is MEI Pharma TTM net income year-on-year change?
Over the past year, MEIP TTM net profit has changed by -$87.76 M (-213.22%)